Skip to main content
Clinical Trials/JPRN-UMIN000008556
JPRN-UMIN000008556
Completed
Phase 3

Prospective study of the efficacy of pancreatic enzyme replacement therapy for non-alcoholic fatty liver disease after pancreatectomy - Prospective study of the efficacy of pancreatic enzyme replacement therapy for non-alcoholic fatty liver disease after pancreatectomy

Hiroshima University Hospital0 sites60 target enrollmentJuly 30, 2012

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Hiroshima University Hospital
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 30, 2012
End Date
October 31, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Patients with acute ischemic heart disease 2\.Patients with preoperative fatty liver/liver cirrhosis, viral hepatitis or alcoholic liver disease 3\.Patients with heavy use of alcohol 4\.Patients with interstitial pneumonia or fibroid lung who require oxygen administration 5\.Patients with chronic renal failure requiring dialysis 6\.Patients with other malignant disease 7\.Patients who have a hypersensitivity to Lipacreon\&\#174; or pig protein 8\.Patients who are diagnosed to be ineligible by the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials